Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues.

Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues.

AIMS: Delta-like ligand 4 (DLL4) is one of five known Notch ligands in mammals and interacts predominantly with Notch 1. DLL4 is induced by vascular endothelial growth factor (VEGF) and acts downstream of VEGF as a 'brake' on VEGF-induced vessel growth, forming an autoregulatory negative...

Bibliografske podrobnosti
Main Authors:	Martinez, J, Müller, M, Turley, H, Steers, G, Choteau, L, Li, J, Sainson, R, Harris, A, Pezzella, F, Gatter, K
Format:	Journal article
Jezik:	English
Izdano:	2009

Podobne knjige/članki

Nuclear and membrane expression of the angiogenesis regulator Delta Like Ligand 4(DLL4) in normal and malignant human tissues (Histopathology (2009) 54 (598-606))
od: Turley, H, et al.
Izdano: (2009)

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
od: Jubb, A, et al.
Izdano: (2009)

The Angiogenesis Regulator and Notch Pathway Activator Delta like Ligand 4 (DII4) Is Widely Expressed by Vascular and Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study
od: Martinez, J, et al.
Izdano: (2009)

The Angiogenesis Regulator and Notch Pathway Activator Delta like Ligand 4 (DI14) Is Widely Expressed by Vascular and Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study
od: Martinez, J, et al.
Izdano: (2009)

Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis?
od: Sainson, R, et al.
Izdano: (2007)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
od: Hiromichi Shimizu, et al.
Izdano: (2014-05-01)

The Role of Dll4/Notch Signaling in Normal and Pathological Ocular Angiogenesis: Dll4 Controls Blood Vessel Sprouting and Vessel Remodeling in Normal and Pathological Conditions
od: Ivan Lobov, et al.
Izdano: (2018-01-01)

Corrigendum.
od: Turley, H, et al.
Izdano: (2009)

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth
od: Oon, C, et al.
Izdano: (2017)

Elucidating the input of notch ligand delta-like 4 (dll4) in zebrafish blood stem cell ontogeny
od: Schneider, J, et al.
Izdano: (2014)

Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
od: Carla Real, et al.
Izdano: (2011-01-01)

Dll4/Notch Signaling Pathway and Tumor Angiogenesis
od: Xinyu DING, et al.
Izdano: (2009-11-01)

Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer.
od: Jubb, A, et al.
Izdano: (2010)

Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells.
od: Williams, C, et al.
Izdano: (2008)

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo.
od: Kristina Preuße, et al.
Izdano: (2015-06-01)

Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma
od: Jubb, A, et al.
Izdano: (2012)

Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.
od: Jubb, A, et al.
Izdano: (2012)

Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
od: Harrington, L, et al.
Izdano: (2008)

Polyethylenimine Triggers Dll4 Degradation to Regulate Angiogenesis In Vitro
od: Binghua Cheng, et al.
Izdano: (2024-02-01)

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
od: Li, J, et al.
Izdano: (2011)

DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
od: Li, J, et al.
Izdano: (2011)

Expression of DLL4 and VEGF in Lung Adenocarcinoma and their Relationship with Angiogenesis in Tumor
od: Xiaoping LI, et al.
Izdano: (2009-02-01)

MPDZ promotes DLL4-induced Notch signaling during angiogenesis
od: Fabian Tetzlaff, et al.
Izdano: (2018-04-01)

RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain
od: Bridges, E, et al.
Izdano: (2020)

Down regulating Delta-4 (DLL4) using RNA interference - a potential future treatment for bladder cancer
od: Patel, N, et al.
Izdano: (2005)

The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro
od: Lena Tveriakhina, et al.
Izdano: (2018-10-01)

New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
od: Oon, C, et al.
Izdano: (2011)

Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms
od: Alejandra G. Serrano, et al.
Izdano: (2024-11-01)

Association of Dll4/notch and HIF-1a -VEGF signaling in the angiogenesis of missed abortion.
od: Yan Fang, et al.
Izdano: (2013-01-01)

Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
od: Qian Tang, et al.
Izdano: (2018-04-01)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
od: Geffers, I, et al.
Izdano: (2007)

The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis.
od: Bridge, G, et al.
Izdano: (2012)

Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis.
od: Alexandre Trindade, et al.
Izdano: (2012-01-01)

Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
od: Nan W. Hultgren, et al.
Izdano: (2020-10-01)

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
od: Charles M. Rudin, et al.
Izdano: (2023-06-01)

Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells.
od: Huizhong Xiong, et al.
Izdano: (2013-01-01)

Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity.
od: Li, J, et al.
Izdano: (2010)

Engineered patterns of Notch ligands Jag1 and Dll4 elicit differential spatial control of endothelial sprouting
od: Laura A. Tiemeijer, et al.
Izdano: (2022-05-01)

Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
od: Liu Ren, et al.
Izdano: (2010-11-01)

O-fucosylation of the notch ligand mDLL1 by POFUT1 is dispensable for ligand function.
od: Julia Müller, et al.
Izdano: (2014-01-01)